|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Xu F, Zhang FQ, Song L and Chen
C: Recent perspectives of bladder cancer diagnostics. Minerva Med.
107:162–166. 2016.PubMed/NCBI
|
|
3
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chou R, Selph SS, Buckley DI, Gustafson
KS, Griffin JC, Grusing SE and Gore JL: Treatment of
muscle-invasive bladder cancer: A systematic review. Cancer.
122:842–851. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zuiverloon TC and Theodorescu D:
Pharmacogenomic considerations in the treatment of muscle-invasive
bladder cancer. Pharmacogenomics. 18:1167–1178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Falzone L, Salomone S and Libra M:
Evolution of cancer pharmacological treatments at the turn of the
third millennium. Front Pharmacol. 9:13002018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Falzone L, Romano GL, Salemi R, Bucolo C,
Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M and Candido
S: Prognostic significance of deregulated microRNAs in uveal
melanomas. Mol Med Rep. 19:2599–2610. 2019.PubMed/NCBI
|
|
11
|
Falzone L, Scola L, Zanghi A, Biondi A, Di
Cataldo A, Libra M and Candido S: Integrated analysis of colorectal
cancer microRNA datasets: Identification of microRNAs associated
with tumor development. Aging (Albany NY). 10:1000–1014. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Falzone L, Candido S, Salemi R, Basile MS,
Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M and
Libra M: Computational identification of microRNAs associated to
both epithelial to mesenchymal transition and NGAL/MMP-9 pathways
in bladder cancer. Oncotarget. 7:72758–72766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guancial EA, Bellmunt J, Yeh S, Rosenberg
JE and Berman DM: The evolving understanding of microRNA in bladder
cancer. Urol Oncol. 32:41 e31–40. 2014. View Article : Google Scholar
|
|
14
|
Xiu Y, Liu Z, Xia S, Jin C, Yin H, Zhao W
and Wu Q: MicroRNA-137 upregulation increases bladder cancer cell
proliferation and invasion by targeting PAQR3. PLoS One.
9:e1097342014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu T, Qin L, Zhu Z, Wang X, Liu Y, Fan Y,
Zhong S, Wang X, Zhang X, Xia L, et al: MicroRNA-31 functions as a
tumor suppressor and increases sensitivity to mitomycin-C in
urothelial bladder cancer by targeting integrin α5. Oncotarget.
7:27445–27457. 2016.PubMed/NCBI
|
|
16
|
He C, Zhang Q, Gu R, Lou Y and Liu W:
miR-96 regulates migration and invasion of bladder cancer through
epithelial-mesenchymal transition in response to transforming
growth factor-β1. J Cell Biochem. 119:7807–7817. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hertzog JH, Dalton HJ, Anderson BD, Shad
AT, Gootenberg JE and Hauser GJ: Prospective evaluation of propofol
anesthesia in the pediatric intensive care unit for elective
oncology procedures in ambulatory and hospitalized children.
Pediatrics. 106:742–747. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Altenburg JD, Harvey KA, McCray S, Xu Z
and Siddiqui RA: A novel 2,6-diisopropylphenyl-docosahexaenoamide
conjugate induces apoptosis in T cell acute lymphoblastic leukemia
cell lines. Biochem Biophys Res Commun. 411:427–432. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang S, Liu Y, Huang L, Zhang F and Kang
R: Effects of propofol on cancer development and chemotherapy:
Potential mechanisms. Eur J Pharmacol. 831:46–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Z, Zhang J, Hong G, Quan J, Zhang L
and Yu M: Propofol inhibits growth and invasion of pancreatic
cancer cells through regulation of the miR-21/Slug signaling
pathway. Am J Transl Res. 8:4120–4133. 2016.PubMed/NCBI
|
|
21
|
Xu J, Xu W and Zhu J: Propofol suppresses
proliferation and invasion of glioma cells by upregulating
microRNA-218 expression. Mol Med Rep. 12:4815–4820. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao H, Li H, Yu G, Xiao W, Hu J, Tang K,
Zeng J, He W, Zeng G, Ye Z and Xu H: MicroRNA-10b promotes
migration and invasion through KLF4 and HOXD10 in human bladder
cancer. Oncol Rep. 31:1832–1838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Li Z, Zhao X, Zuo X and Peng Z:
miR-10b promotes invasion by targeting HOXD10 in colorectal cancer.
Oncol Lett. 12:488–494. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang YY, Li L, Ye ZY, Zhao ZS and Yan ZL:
MicroRNA-10b promotes migration and invasion through Hoxd10 in
human gastric cancer. World J Surg Oncol. 13:2592015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cassinello F, Prieto I, del Olmo M, Rivas
S and Strichartz GR: Cancer surgery: How may anesthesia influence
outcome? J Clin Anesth. 27:262–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soltanizadeh S, Degett TH and Gögenur I:
Outcomes of cancer surgery after inhalational and intravenous
anesthesia: A systematic review. J Clin Anesth. 42:19–25. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Z, Kou D, Li Z, He Y, Yu W and Du H:
Effects of propofol-dexmedetomidine combination on ischemia
reperfusion-induced cerebral injury. NeuroRehabilitation.
35:825–834. 2014.PubMed/NCBI
|
|
29
|
Shin IW, Jang IS, Lee SH, Baik JS, Park
KE, Sohn JT, Lee HK and Chung YK: Propofol has delayed myocardial
protective effects after a regional ischemia/reperfusion injury in
an in vivo rat heart model. Korean J Anesthesiol. 58:378–382. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu YB, Du QH, Zhang MY, Yun P and He CY:
Propofol suppresses proliferation, invasion and angiogenesis by
down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal
squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci.
17:2486–2494. 2013.PubMed/NCBI
|
|
31
|
Xu YB, Jiang W, Zhao FR, Li G, Du QH,
Zhang MY and Guo XG: Propofol suppresses invasion and induces
apoptosis of osteosarcoma cell in vitro via downregulation of
TGF-β1 expression. Eur Rev Med Pharmacol Sci. 20:1430–1435.
2016.PubMed/NCBI
|
|
32
|
Wang ZT, Gong HY, Zheng F, Liu DJ and Yue
XQ: Propofol suppresses proliferation and invasion of gastric
cancer cells via downregulation of microRNA-221 expression. Genet
Mol Res. 14:8117–8124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu B, Gao W, Zhou H, Miao X, Chang Y, Wang
L, Xu M and Ni G: Propofol induces apoptosis of breast cancer cells
by downregulation of miR-24 signal pathway. Cancer Biomark.
21:513–519. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun H and Gao D: Propofol suppresses
growth, migration and invasion of A549 cells by down-regulation of
miR-372. BMC Cancer. 18:12522018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang P, Hong H, Sun X, Jiang H, Ma S,
Zhao S, Zhang M, Wang Z, Jiang C and Liu H: MicroRNA-10b regulates
epithelial-mesenchymal transition by modulating
KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal
carcinoma cells. Am J Cancer Res. 6:141–156. 2016.PubMed/NCBI
|
|
36
|
Bahena-Ocampo I, Espinosa M,
Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A,
Maldonado V, Melendez-Zajgla J and Garcia-Lopez P: miR-10b
expression in breast cancer stem cells supports self-renewal
through negative PTEN regulation and sustained AKT activation. EMBO
Rep. 17:648–658. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Y, Liu J, Fan Y, Fan Y, Li X, Dong M,
Liu H and Chen J: Expression levels of microRNA-145 and
microRNA-10b are associated with metastasis in non-small cell lung
cancer. Cancer Biol Ther. 17:272–279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang L, Sun J, Wang B, Ren JC, Su W and
Zhang T: MicroRNA-10b triggers the epithelial-mesenchymal
transition (EMT) of laryngeal carcinoma Hep-2 cells by directly
targeting the E-cadherin. Appl Biochem Biotechnol. 176:33–44. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang
J, Wang X, You Y, Yang Z and Liu N: MicroRNA-10b induces glioma
cell invasion by modulating MMP-14 and uPAR expression via HOXD10.
Brain Res. 1389:9–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakayama I, Shibazaki M, Yashima-Abo A,
Miura F, Sugiyama T, Masuda T and Maesawa C: Loss of HOXD10
expression induced by upregulation of miR-10b accelerates the
migration and invasion activities of ovarian cancer cells. Int J
Oncol. 43:63–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
